Sentinel node mapping with radiotracer alone in vulvar cancer: a five year single-centre experience and literature review

Purpose of investigation: The pathologic status of lymph node represents the most important prognostic factor in vulvar cancer patients, but a complete groin dissection is associated with high post-operative morbidity. Sentinel lymph node (SLN) could be representative of the totality of regional lymph nodes and consequently its biopsy might have a significant impact on clinical management in vulvar cancer patients. Materials and Methods: From January 2006 to December 2010 45 patients with vulvar carcinoma are evaluated. Preoperative lymphatic mapping with technetium–99m–labeled nanocolloid was performed in all patients, followed by radioguided intraoperative detection. The detection rate is 100% of patients. All the SLNs were dissected separately for histopathological evaluation and a routine inguinofemoral lymphadenectomy was performed. Results: Nine patients had positive SLNs. In the remaining 36 patients with negative SLNs, one of them showed positive non-SLNs at histological examination. It was the only false negative case in the present series. Conclusions: Based on literature review, lymphoscintigraphy and sentinel node biopsy under gamma-detecting probe guidance offer a reliable and careful method to identify sentinel node in early vulvar cancer. Taking certain guidelines, SLN biopsy seems to be a safe alternative to inguinofemoral node dissection in order to reduce morbidity of surgical treatment.

Vulvar cancer; Sentinel-node biopsy; Squamous cells carcinoma; Radiotracer; Groin dissection.

[1] Tropè C.G., Makar A.P.H.: “Epidemiology, etiology, screening, prevention and diagnosis in female genital cancer. Review”. Curr. Opin. Oncol., 1991, 3, 908.

[2] American Cancer Society: “Cancer Facts & Figures 2010”. Atlanta: American Cancer Society, 2010. Available at: http://www.cancer.org/acs/groups/content/@nho/documents/document/acspc-024113.pdf

[3] Hampl M., Deckers-Figiel S., Hampl J.A., Rein D., Bender H.G. : “New aspects of vulvar cancer: changes in localization and age of onset.” Gynecol Oncol, 2008, 109, (3),340.

[4] Hampl M., Sarajuuri H., Wentzensen N., Bender H.G., Kueppers V.: “Effect of human papillomavirus vaccines on vulvar, vaginal and anal intraepithelial lesions and vulvar cancer.” Obstet Gynecol, 2006, 108,1361.

[5] De Vuyst H., Clifford G.M., Nascimento M.C., Madeleine M.M., Franceschi S.: “Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: a meta-analysis”. Int. J. Cancer, 2009, 124, 1626.

[6] Hacker N.F.: ”Vulvar cancer.” In: Berek J.S., Hacker N.F. (eds). Practical gynecologic oncology. 3rd ed. Baltimore, MD: Williams & Wilkins, 2000, 553.

[7] Parry-Jones E.: “Lymphatics of the vulva.” J. Obstet. Gynaecol. Br. Emp., 1963, 70, 751.

[8] Van der Velden K.: “Some aspects of the management of squamous cell carcinoma of the vulva”. In: Shaw R.W., Luesley D., Monga A.K. (eds). Gynaecology, 4th ed. Edinburgh: Churchill Livingstone, 2011.

[9] Stehman F., Bundy B., Dvoretsky P.M., Creasman W.T.: “Early stage I carcinoma of the vulva treated with ipsilateral superficial inguinal lymphadenectomy and modified radical hemivulvectomy: a prospective study of the Gynecologic Oncology Group”. Obstet. Gynecol., 1992, 79, 490.

[10] De Hullu J.A., Hollema H., Lolkema S., Boezen M., Boonstra H., Burger M.P.: “Vulvar carcinoma: the price of less radical surgery”. Cancer, 2002, 95, 2231.

[11] Gaarenstroom K.N., Kenter G.G., Trimbos J.B., Agous I., Amant F., Peters A.A., Vergote I.: “Postoperative complication after vulvectomy and inguinofemoral lymphadenectomy using separate groin incision”. Int. J. Gynecol. Cancer, 2003, 13, 522.

[12] Levenback C., Burke T.W., Gershenson D.M., Morris M., Malpica A., Ross M.I.: “Intraoperative lymphatic mapping for vulvar cancer”. Obstet. Gynecol., 1994, 84, 163.

[13] Burke T.W., Levenback C., Coleman R.L., Malpica A., Lucas K.R., Gershenson D.M.: “Potential application of intraoperative lymphatic mapping in vulvar cancer”. Gynecol. Oncol., 1995, 59, 216.

[14] Levenback C., Coleman R.L., Burke. T.W., Bodurka-Bevers D., Wolf J.K., Gershenson DM: “Intraoperative lymphatic mapping and sentinel node identification with blue dye in patients with vulvar cancer.” Gynecol. Oncol., 2001, 84, 449.

[15] Rouzier R., Haddad B., Dubernard G.: “ Inguinofemoral dissection for carcinoma of the vulva: effect of modifications of extent and technique on morbidity and survival”. J. Am. Coll. Surg., 2003, 196, 442.

[16] Gould N., Kamelle S., Tillmanns T.: “Predictors of complications after inguinal lymphadenectomy”. Gynecol. Oncol., 2001, 82, 329.

[17] Oonk M.H., Hollema H., De Hullu J.A., van der Zee A.G.: “Prediction of lymph node metastases in vulvar cancer: a review”. Int. J. Gynecol. Cancer, 2006, 16, 963.

[18] De Hullu J.A., Doting E., Piers D.A., Hollema H., Aalders J.G., Koops H.S. et al.: “Sentinel lymph node identification with technetium- 99m-labeled nanocolloid in squamous cell cancer of the vulva”. J. Nucl. Med., 1998, 39, 1381.

[19] De Cesare S.L., Fiorica J.V., Roberts W.S., Reintgen D., Arango H., Hoffman M.S., et al.: “A pilot study utilizing intraoperative lymphoscintigraphy for identification of the sentinel lymph nodes in vulvar cancer”. Gynecol. Oncol., 1997, 66, 425.

[20] Coleman R.L.: “Vulvar Lymphatic Mapping: Coming of Age? Editorial”. Ann. Surg. Oncol., 2002, 9, 823.

[21] De Hullu J.A., Oonk M.H.M., Ansink A.C., Hollema H., Jager P.L., van der Zee A.G.: “Pitfalls in the sentinel lymph node procedure in vulvar cancer”. Gynecol. Oncol., 2004, 94, 10.

[22] Ansink A.C., Sie-Go D.M., van der Velden J., Sijmons E.A., de Barros Lopes A., Monaghan J.M., et al.: “Identification of sentinel lymph nodes in vulvar carcinoma patients with the aid of a patent blue V injection: a multicenter study.” Cancer, 1999, 86, 652.

[23] De Cicco C., Sideri M., Bartolomei M., Grana C., Cremonesi M., Fiorenza M., et al.: “Sentinel node biopsy in early vulvar cancer”. Br. J. Cancer, 2000, 82, 295.

[24] Sideri M., De Cicco C., Maggioni A., Colombo N., Bocciolone L., Trifirò G. et al.: “ Detection of sentinel nodes by lymphoscintigraphy and gamma probe guided surgery in vulvar neoplasia.” Tumori, 2000, 86, 359.

[25] Sliutz G., Reinthaller A., Lantzsch T., Mende T., Sinzinger H., Kainz C., Koelbl H.: “Lymphatic mapping of sentinel nodes in early vulvar cancer”. Gynecol. Oncol., 2002, 84, 449.

[26] Puig-Tintoré L.M., Ordi J., Vidal-Sicart S., Torné A., Pahisa J., Iglesias X.: “Further data on the usefullness of sentinel lymph node identification and ultrastaging in vulvar squamous cell carcinoma”. Gynecol. Oncol., 2003, 88, 29.

[27] Moore R.G., DePasquale S.E., Steinhoff M.M., Gajewski W., Steller M., Noto R., Falkenberry S. “Sentinel node identification and the ability to detect metastatic tumor to inguinal lymph nodes in squamous cell cancer of the vulva.” Gynecol. Oncol., 2003, 89, 475.

[28] Merisio C., Berretta R., Gualdi M., Pultrone D.C., Anfuso S., Agnese G., et al.: “Radioguided sentinel lymph node detection in vulvar cancer”. Int. J. Gynecol. Cancer, 2005, 15, 493.

[29] Nyberg R.H., Iivonen M., Parkkinen J., Kuoppala T., Mäenpää J.U.: “Sentinel node and vulvar cancer: a series of 47 patients”. Acta Obstet. Gyn. Scan, 2007, 86, 615.

[30] Hampl M., Hantschmann P., Michels W., Hillemanns P. German Multicenter Study Group.: “Validation of the accuracy of the sentinel lymph node procedure in patients with vulvar cancer: results of a multicenter study in Germany”. Gynecol. Oncol., 2008, 111, 282.

[31] Achimas-Cadariu P., Harter P., Fisseler-Eckhoff A., Beutel B., Traut A., Du Bois A.: “Assessment of the sentinel lymph node in patients with invasive squamous carcinoma of the vulva”. Acta Obstet. Gynecol. Scand., 2009, 88, 1209.

[32] Levenback C.F.: “Sentinel node (SN) biopsy in patients with vulvar cancer: a Gynecologic Oncology Group (GOG) study”. J. Clin. Oncol., 2009, 27, 15s.

[33] Lindell G., Jonsson C., Ehrsson R.J., Jacobsson H., Danielsson K.G., Källström B.N., Larson B.: “Evaluation of preoperative lymphoscintigraphy and sentinel node procedure in vulvar cancer”. Eur. J. Obstet. Gynecol. Reprod. Biol., 2010, 152, 91.

[34] Radziszewski J., Kowalewska M., Jedrzejczak T., Kozlowicz- Gudzinska I., Nasierowska-Guttmejer A., Bidzinski M., et al.: “The accuracy of the sentinel lymph node concept in early stage squamous cell vulvar carcinoma”. Gynecol. Oncol., 2010, 116, 473.

[35] Ennik T.A., Allen D.G., Bekkers R.L., Hyde S.E., Grant P.T.: “Effect of previous surgery on the detection of sentinel node in women with vulvar cancer”. Int. J. Gynecol. Cancer, 2011, 21, 1679.

[36] Levenback C.F., Ali S., Coleman R.L., Gold M.A., Fowler J.M., Judson P.L., et al.: “Lymphatic mapping and sentinel lymph node biopsy in women with squamous cell carcinoma of the vulva: a Gynecologic Oncology Group study”. J. Clin. Oncol., 2012, 30, 3786.

[37] Zekan J., Mutvar A., Huic D.,Petrovic D., Karelovic D., Mitrovic L.: “Reliability of sentinel node assay in vulvar cancer: the first Croatian validation trial”. Gynecol. Oncol., 2012, 126, 99.

[38] Louise-Sylvestre C., Evangelista E., Leonard F., Itti E., Meignan M., Paniel B.J.: “Sentinel node localization should be interpreted with caution in midline vulvar cancer”. Gynecol. Oncol., 2005, 97, 151.

[39] Hauspy J., Beiner M., Harley I., Ehrlich L., Rasty G., Covens A.: “Sentinel lymph node in vulvar cancer”. Cancer, 2007, 5, 1015.

[40] Van der Zee A.G., Oonk M.H., De Hullu J.A., Ansink A.C., Vergote I., Verheijen R.H., et al:. “Sentinel node dissection is safe in the treatment of early-stage vulvar cancer”. J. Clin. Oncol., 2008, 6, 884

[41] Raspagliesi F., Ditto A., Fontanelli R., Maccauro M., Carcangiu M.L., Parazzini F., et al.: “False-negative sentinel node in patients with vulvar cancer: a case study”. Int. J. Gynecol. Cancer, 2003, 13, 361.

[42] Cox C.E., Dupont E., Whitehead G.F., Ebert M.D., Nguyen K., Peltz E.S., et al.: “Age and body mass index may increase the chance of failure in sentinel lymphnode biopsy for women with breast cancer”. Breast J., 2002, 8, 88.

[43] Robison K., Steinhoff M.M., Granai C.O., Brard L., Gajewski W., Moore R.G.: “Inguinal sentinel node dissection versus standard inguinal node dissection in patients with vulvar cancer: a comparison of the size of metastases detected in inguinal lymph nodes”. Gynecol. Oncol., 2006, 101, 24.

[44] Oonk M.H., van Hemel B.M., Hollema H., de Hullu J.A., Ansink A.C., Vergote I., et al.:“ Size of sentinel node metastasis and chances of non-sentinel-node involvement and survival in early stage vulvar cancer: results from GROINSS-V, a multicentre observational study”. Lancet Oncol., 2010, 11, 646.

[45] Johann S., Klaeser B., Krause T., Mueller M.D..: “Comparison of outcome and recurrence-free survival after sentinel lymph node biobsy and lymphadenectomy in vulvar cancer”. Gynecol. Oncol., 2008, 110, 324.